Bio-AMD Inc. (fka BIAD)

[derkampfer]

Thx 13. And yes. I’m sure Tom could use all the encouragement they can get.

This is truly an extraordinary development. Being 4x as sensitive in a hand held POC device with immediate results versus the next best solution in an hour long lab test is the difference in a proper response or death by heart attack.

Not sure where this is all going to lead but the market clearly understands the potential based on ZENOSENSE’s price action.

What the market doesn’t clearly understand is that today’s news is all of Bio-AMD’s doing and MML is 60% BIAD and only 40% ZENO.

I would also venture to say that this news marks a “ Milestone “ and BIAD should receive operating revenue as a result. Hope Tomnupdates shareholders on these matters.